Kaposi's sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis. 1998

P S Moore, and Y Chang
Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Molecular biologic studies of Kaposi's sarcoma-associated herpesvirus (KSHV) have identified a number of potential viral oncogenes that may contribute to KSHV-related neoplasia including a D-type cyclin, an IL-6-like cytokine, and a novel member of the interferon regulatory factor family. KSHV is functionally related to other DNA tumor viruses by encoding specific proteins to inhibit pRb, pro-apoptotic, and interferon-signaling tumor suppressor pathways. The virus appears to employ molecular piracy of cellular regulatory genes as a mechanism to avoid cellular antiviral responses. The transparency of the KSHV genome allows ready identification of the cellular regulatory pathways which may be involved in transformation by KSHV. This provides strong support to the notion that some tumor suppressor pathways serve the dual function of being antiviral pathways to induce cell cycle arrest, apoptosis, and enhanced cell-mediated immunity in response to virus infection. Neoplasia may result from specific viral strategies to overcome these host defense pathways.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012514 Sarcoma, Kaposi A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause. Kaposi Sarcoma,Kaposi's Sarcoma,Multiple Idiopathic Pigmented Hemangiosarcoma,Kaposis Sarcoma,Sarcoma, Kaposi's
D016679 Genome, Viral The complete genetic complement contained in a DNA or RNA molecule in a virus. Viral Genome,Genomes, Viral,Viral Genomes
D019288 Herpesvirus 8, Human A species in the genus RHADINOVIRUS, subfamily GAMMAHERPESVIRINAE, isolated from patients with AIDS-related and "classical" Kaposi sarcoma. Herpesvirus, Kaposi Sarcoma-Associated,KSHV,Kaposi Sarcoma-Associated Herpesvirus,HHV-8,Herpesvirus, Kaposi's Sarcoma-Associated,Human Herpesvirus 8,Kaposi's Sarcoma-Associated Herpesvirus,Herpesvirus, Kaposi Sarcoma Associated,Herpesvirus, Kaposi's Sarcoma Associated,Herpesvirus, Kaposis Sarcoma-Associated,Herpesviruses, Kaposi's Sarcoma-Associated,Kaposi Sarcoma Associated Herpesvirus,Kaposi's Sarcoma Associated Herpesvirus,Kaposi's Sarcoma-Associated Herpesviruses,Kaposis Sarcoma-Associated Herpesvirus,Sarcoma-Associated Herpesvirus, Kaposi,Sarcoma-Associated Herpesviruses, Kaposi's

Related Publications

P S Moore, and Y Chang
April 2000, Journal of hematotherapy & stem cell research,
P S Moore, and Y Chang
February 2004, Seikagaku. The Journal of Japanese Biochemical Society,
P S Moore, and Y Chang
January 2010, Advances in virus research,
P S Moore, and Y Chang
May 2000, Microbes and infection,
P S Moore, and Y Chang
December 2008, Virologica Sinica,
P S Moore, and Y Chang
January 2006, Cold Spring Harbor symposia on quantitative biology,
P S Moore, and Y Chang
January 1998, Advances in cancer research,
Copied contents to your clipboard!